Canna~Fangled Abstracts Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists As Potential Treatment for Inflammatory Kidney Diseases. 2015 Jul 21. doi: 10.1002/cmdc.201500218. Nettekoven M1, Adam JM2, Bendels S2, Bissantz C2, Fingerle J3, Grether U2, Grüner S3, Guba W2, Kimbara A2, Ottaviani…Freedom WaresJuly 21, 2015
